British boxer ‘Kid Galahad’ banned For two years
UK Anti-Doping (UKAD) has today confirmed that former British, European and WBC International Super Bantamweight boxing champion Abdul Barry Awad, also known as Kid Galahad, has been suspended from all sport for two years following an Anti-Doping Rule Violation.
Awad (25) from Sheffield, tested positive for a metabolite of stanozolol, an exogenous anabolic androgenic steroid, following an in-competition test on 20 September 2014, after a bout against former WBO Super Bantamweight champion and former WBC World Youth champion Adeilson Dos Santos.
Following the closure of all appeal windows, Awad has been banned from all competitive sport from 20 September 2014 until midnight on 19 September 2016. Awad is also disqualified from his bout against Dos Santos and forfeits any associated prize money.
The full written decision can be found under current rule violations on the UKAD website.
UKAD’s Chief Executive, Nicole Sapstead, said:
“Kid Galahad is one of the country’s leading boxing talents and through his own actions he has jeopardised his promising career, and his reputation."
“All athletes, at all levels, need to understand the importance of Strict Liability – they are solely responsible for any banned substance that is found in their system, regardless of how it got there or whether there was an intention to cheat or not."
“The principle of Strict Liability can be challenging for an athlete. They have to ensure that they understand the anti-doping rules and that their family, friends, coaches and athlete support personnel understand them too. They need to be aware of the risks their career faces if they test positive, and manage that risk at all times.”
To find out further information about an athlete’s responsibilities under the 2015 WADA Code, and learn more about Strict Liability, visit the athlete zone on the UKAD website.
- Tags: Anti-Doping | Anti-Doping Rule Violations (ADRV) | Boxing | UK Anti-Doping (UKAD) | United Kingdom (UK) | World Anti-Doping Code (WADC)